A synthetic peptide for use as a blocking control in assays to test for specificity of PPIA antibody, Alternative Names: PPIA control peptide, PPIA antibody Blocking Peptide, Anti-PPIA Blocking Peptide, Peptidylprolyl Isomerase A Blocking Peptide, Cyclophilin A Blocking Peptide, CYPA Blocking Peptide, CYPH Blocking Peptide, MGC117158 Blocking Peptide, MGC12404 Blocking Peptide, MGC23397 Blocking Peptide
Optimal conditions should be determined by the investigator
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
Buffer
PBS
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20 °C long term.
Target
PPIA
(Peptidylprolyl Isomerase A (Cyclophilin A) (PPIA))
Hintergrund
PPIA is a member of the peptidyl-prolyl cis-trans isomerase (PPIase) family. PPIases catalyze the cis-trans isomerization of proline imidic peptide bonds in oligopeptides and accelerate the folding of proteins. PPIA is a cyclosporin binding-protein and may play a role in cyclosporin A-mediated immunosuppression. The protein can also interact with several HIV proteins, including p55 gag, Vpr, and capsid protein, and has been shown to be necessary for the formation of infectious HIV virions.